Description
Vaud. L'Hôpital Cantonal de Fribourg Performed and led all start-up aspects for a Phase II multi-center study for Crohn's disease. Monitored 120 patients using a PAF antagonist for asthma, including pre-study visits, site initiations, monitoring, and close down. Wrote protocol and designed CRF for a methacholine challenge study. Monitored pharmacokinetic Phase I studies co-wrote final study report.
Work Experience
| COMPANY | POSITION HELD | DATES WORKED |
|---|---|---|
| (Confidential) | Consultant Study Manager | 5/2016 - Present |
| Eisai Pharmaceuticals | Senior Clinical Study Manager Consultant Oncology | 1/2016 - 1/2016 |
| Novartis | Clinical Trial Head Oncology | 1/2012 - 1/2015 |
| Medarex Inc. | Assistant Director, Clinical Operations | 1/2008 - 1/2008 |
| Dlf International Consulting | Consultant Study Manager | 1/2000 - 1/2007 |
| Schering Plough Research | Study Team Leader Project Leader 6 Phase Iii Asthma Trials Cro Liaison | 1/1996 - 1/2000 |
| Hoffmann La Roche Inc. | Sr. Clinical Research Associate Cardiovascular Clinical Research Associate Broncho Pulmonary | 1/1994 - 1/1996 |
| Icu La Clinique De Genolier | Surgical And Medical Cardiac Intensive Care Nurse, Switzerland | 1/1991 - 1/1991 |
| Hospital. | Cardio/Thoracique Surgery | 1/1991 - 1/1991 |
Accomplishments
Highlights:
Job Skills
Keywords
